How far should we lower blood pressure in the elderly

Cardiovascular Drugs and Therapy

Volumn 15, Issue 3, 2001, Pages 275-279

  Hansson, L ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antihypertensive treatment; Elderly; Hypertension; Intervention

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROCHLOROTHIAZIDE; METHYLDOPA; METOPROLOL; PINDOLOL; RESERPINE; TRIAMTERENE;

AGED; AGING; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; HUMAN; HYPERTENSION; MEDICAL INFORMATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGED; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION;

EID: 0034771398     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011928609508     Document Type: Conference Paper

References (25)

1. Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg
2. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg
3. Effects of treatment on mortality in hypertension. III. Influence of age, diastolic blood pressure, and prior cardiovascular disease; further analysis of side effects
4. Five-year findings of the HDFP. II. Mortality by race-sex and age
5. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension
6. Treatment of mild hypertension in the elderly: A study initiated and administered by the National Heart Foundation of Australia
7. Australian therapeutic trial in mild hypertension
8. Mortality and morbidity results from the European working party on high blood pressure in the elderly trial
9. Randomised trial of treatment of hypertension in elderly patients in primary care
10. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
11. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension)
12. Medical Research Council trial of treatment of hypertension in older adults: Principal results
13. The 1993 guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting
14. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V)
15. Shanghai trial of nifedipine in the elderly (STONE)
16. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
17. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension
18. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
19. STOP-hypertension-2: A prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension
20. Prospective randomized open blinded end-point (PROBE) study: A novel design for intervention trials
21. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish trial in old patients with hypertension-2 study
22. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. Principal results of the Hypertension optimal treatment (HOT) randomised trial
23. Study on cognition and prognosis in the elderly (SCOPE)
24. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure lowering treatments
25. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials